Clinical Trial Update: A Study of TG103 Injection in Overweight or Obesity [Phase 2]

View source ↗

Summary

Phase 2 study of TG103 injection in overweight or obesity is ongoing with status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overweight or Obesity

Drugs mentioned

• TG103

Snippet

Sponsor: CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. | Conditions: Overweight or Obesity | Phase 2 | Status: UNKNOWN